Wells Fargo Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $660
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Brandon Couillard maintains an Overweight rating on Thermo Fisher Scientific (NYSE:TMO) but lowers the price target from $670 to $660.
October 24, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Wells Fargo has maintained its Overweight rating on Thermo Fisher Scientific but has slightly reduced the price target from $670 to $660, indicating a minor adjustment in expectations.
The Overweight rating suggests continued confidence in TMO's performance, but the slight reduction in price target indicates a minor adjustment in expectations. This is likely to have a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100